Post Profile

Mylan's EpiPen: Poster Child for Corporate Greed

The soaring cost of EpiPens is the latest in a long run of wildly increased costs of prescription drugs that are unaffordable to many, such as Turing's Daraprim for toxoplasmosis (5,000 percent overnight price increase) and Gilead's Sovaldi for hepatitis C ($84,000 for a 12-week treatment). These greedy grabs by their manufacturers create public anger and even congressional inquiries, but the corporate system of price escalations grinds on without relief on the horizon as Big PhRMA and its lobbyists continue to prevail.
read more


Related Posts

Sarah Jessica Parker Cuts Ties with Drug Company Mylan Over EpiPen Price Increase

Pop Culture / Celebrity : Just Jared

Sarah Jessica Parker is ending her relationship with Mylan, the company that manufactures EpiPen, a life-saving medication for those with severe anaphylaxis. Each individual EpiPen now costs $500 for one injector. The drug apparentl...

Clinton calls for reduction in cost of allergy drug EpiPen

Health : Reuters: Health

WASHINGTON (Reuters) - Hillary Clinton called on pharmaceutical company Mylan NV to voluntarily drop the price of their severe allergy treatment drug EpiPen, which has increased in price by 400 percent in the past decade.

Not everyone is buying into Mylan's EpiPen price plan (MYL)

Business & Finance : Business Insider: Money Game

Mylan Pharmaceuticals said Thursday that it would be giving a $300 "savings card" discount for a two-pack of EpiPens, amid pressure to cut the price of the drug. Mylan has increased the price of EpiPen by 500% since it acquired the ...

Congress Demand An Explanation For Epipen Price Increases; Mylan Slides

Business & Finance : Zero Hedge

In a rerun of last summer's political interference in pharmaceutical pricing spearheaded by both Bernie Sanders and Hillary Clinton, which initially focused on Martin Shrekli's price hike of the Turing Pharmaceuticals Daraprim drug,...

Outrage Over EpiPen Pricing

Politics / US Politics : Washington Watch

The huge increase of the list price for the severe-allergy drug injector has led to backlash against Mylan, the latest in a string of pharmaceutical companies accused of price gouging. … Click to Continue »


Copyright © 2016 Regator, LLC